Suchergebnisse - "Tabarsi, Payam"

PubPharm (363)

81

Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients

enthalten in: International immunopharmacology | 2021

von Baghaei, P. | Dastan, F. | Marjani, M. | +14

82

Late Post-Coronavirus Disease 2019 Inflammatory Syndrome : A Case Experience with Tocilizumab

enthalten in: Tanaffos | 2021

von Tabarsi, P. | Afzal, G. | Eskandari, R. | +1

83

NRITLD Protocol for the Management of Outpatient Cases of COVID-19

enthalten in: Tanaffos | 2021

von Rezaei, M. | Jamaati, H. | Tabarsi, P. | +3

84

Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak : Iranian"247" National Committee's position paper on primary percutaneous coronary intervention

enthalten in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions | 2021

von Sadeghipour, P. | Talasaz, A. | Eslami, V. | +22

85

Efficacy of Early Prone Positioning Combined with Noninvasive Ventilation in COVID-19

enthalten in: Tanaffos | 2021

von Hashemian, S. | Jamaati, H. | Malekmohammad, M. | +3

86

Bronchial Angioembolization for Management of Hemoptysis Due to Pulmonary Tuberculosis

enthalten in: Tanaffos | 2021

von Seyyedi, S. | Tabarsi, P. | Sadr, M. | +8

87

Clinical and demographic characteristics of patients with COVID-19 infection : Statistics from a single hospital in Iran

enthalten in: Human antibodies | 2021

von Samsami, M. | Mehravaran, E. | Tabarsi, P. | +5

88

Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients

enthalten in: Frontiers in immunology | 2021

von Mortaz, E. | Tabarsi, P. | Jamaati, H. | +10

89

COVID-19 : Molecular and Cellular Response

enthalten in: Frontiers in cellular and infection microbiology | 2021

von Alipoor, S. | Mortaz, E. | Jamaati, H. | +4

90

Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases : An Experience with Iranian Formulated Dosage Form

enthalten in: Iranian journal of pharmaceutical research : IJPR | 2021

von Tabarsi, P. | Vahidi, H. | Saffaei, A. | +24